March 5, 2021 Comments Off on New patent for Neurocrine drug INGREZZA Posted in: Patent Added Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first on …
March 5, 2021 Comments Off on New patent for Horizon Pharma drug PROCYSBI Posted in: Patent Added Annual Drug Patent Expirations for PROCYSBI Procysbi is a drug marketed by Horizon Pharma Usa and is included in two NDAs. There are sixteen patents protecting this drug. Drug patent…
The post New patent for Horizon Pharma drug PROCYSBI appeared first …